Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837432 · ClinicalTrials.gov registry record · Early Phase 1
The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression
A Early Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 192
- Enrollment target
NCT02837432: Completed Early Phase 1 study, sponsored by Stanford University.
NCT02837432 is a Early Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 192 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02837432, a Early Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 192 participants
- Enrollment target
Study Summary
There is good evidence to suggest that the pathological version of sadness that people with Major Depression experience could be caused by the failure of the hormone cortisol to properly inhibit sadness-related brain activity in the subgenual cingulate cortex. This project investigates if the subgenual cingulate cortex has become insensitive to cortisol in patients with depression and tests for variants of the cortisol receptor genes that could predispose individuals to develop cortisol insensitivity.
Interventions
- DRUG Placebo
- DRUG Hydrocortisone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-11-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02837432
The ClinicalTrials.gov registry entry for NCT02837432 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02837432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02837432 about?
NCT02837432 is a clinical study titled "The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression". There is good evidence to suggest that the pathological version of sadness that people with Major Depression experience could be caused by the failure of the hormone cortisol to properly inhibit sadness-related brain activity in the subgenual cingulate cortex. This project investigates if the subgen...
What is the current status of trial NCT02837432?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 192 participants. The study started on 2016-07. Estimated completion is 2020-11-15.
What interventions are being tested in trial NCT02837432?
The interventions under investigation include: Placebo (DRUG), Hydrocortisone acetate (DRUG).
Who is sponsoring clinical trial NCT02837432?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.